MS 8209

Known as: MS-8209 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Amphotericine B (AmB), a macrolide polyene antibiotic, is one of a few drugs that has shown therapeutic properties in scrapie… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
The histopathological response of scrapie-infected hamsters treated at the late stage of the infection with an "anti-scrapie… (More)
Is this relevant?
2000
2000
The mode and the site of action of the major antiscrapie drugs have been studied by investigating their effects on the abnormal… (More)
Is this relevant?
2000
2000
Amphotericin B derivatives, such as MS-8209, have been evaluated as a therapeutic approach to human immunodeficiency virus (HIV… (More)
  • figure 1
  • figure 2
Is this relevant?
1999
1999
Amphotericin B (AmB) has been shown to delay hamster scrapie. Infectivity studies have been performed previously using AmB in… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1997
1997
Amphotericin B (AmB) is one of the few drugs able to prolong survival times in experimental scrapie and delays the accumulation… (More)
Is this relevant?
1996
1996
Mice were infected intracerebrally with the bovine spongiform encephalopathy (BSE) or the scrapie agent and treated during 8… (More)
Is this relevant?
1995
1995
To test the efficacy of a new amphotericin B derivative, MS-8209, in delaying scrapie, hamsters were infected intracerebrally… (More)
  • table 1
  • figure 1
Is this relevant?
1994
1994
Transmissible subacute spongiform encephalopathies (TSSE) are neurodegenerative diseases characterized by the presence of a… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 2
Is this relevant?
1992
1992
The in vitro and in vivo toxicities and activities of MS-8209, a new hydrosoluble amphotericin B (deoxycholate-amphotericin B [D… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?